title: Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease.
abstract: OBJECTIVE
  Serum concentrations of insulin-like growth factor-I are decreased in liver cirrhosis. However, this growth factor is bound for the most part to specific binding proteins that are known to modulate biological actions. Plasma insulin-like growth factor binding proteins are predominantly synthesized in the liver.
  
  
  METHODS
  The effect of liver disease on basal and on growth hormone-stimulated serum concentrations of total and "free" insulin-like growth factor-I and on insulin-like growth factor binding protein patterns is reported. Sera were obtained from 20 patients with non-cirrhotic chronic liver diseases and from 20 patients with cirrhosis before and 24 h after a single subcutaneous dose of growth hormone. Samples were analyzed using radioimmunoassays, gel chromatography, ligand blotting and immunoblotting.
  
  
  RESULTS
  In cirrhosis, serum concentrations of total and "free" insulin-like growth factor-I were decreased, the binding protein pattern was changed profoundly showing a reduction in the 150 kD complex and an increase in the 30-40 kD complexes. Concentrations of binding protein-1 and -2 were increased, while that of binding protein-3 was decreased in cirrhosis. The response to growth hormone was blunted. These changes were related to the degree of liver dysfunction as assessed by the Child-Pugh classification.
  
  
  CONCLUSIONS
  A pathogenetic link of altered bio-availability of insulin-like growth factor-I to clinical characteristics of advanced liver disease, e.g. insulin resistance or skeletal muscle wasting, may be suggested by the present data.
authors.affiliation: Department of Medicine, Georg-August-Universität, Göttingen, Germany.
authors.forename: J G
authors.initials: JG
authors.lastname: Scharf
authors.forename: F
authors.initials: F
authors.lastname: Schmitz
authors.forename: J
authors.initials: J
authors.lastname: Frystyk
authors.forename: C
authors.initials: C
authors.lastname: Skjaerbaek
authors.forename: H
authors.initials: H
authors.lastname: Moesus
authors.forename: W F
authors.initials: WF
authors.lastname: Blum
authors.forename: G
authors.initials: G
authors.lastname: Ramadori
authors.forename: H
authors.initials: H
authors.lastname: Hartmann
mesh_terms: D000328:Adult; D000368:Aged; D015153:Blotting, Western; D002850:Chromatography, Gel; D002908:Chronic Disease; D005260:Female; D013006:Growth Hormone; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008103:Liver Cirrhosis / Q000097:blood*; D008107:Liver Diseases / Q000097:blood*; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight
chemical_list: D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone